Monophosphoryl lipid A stimulated up-regulation of nitric oxide synthase and nitric oxide release by human monocytes in vitro

Immunopharmacology

Volumn 37, Issue 2-3, 1997, Pages 175-184

  Saha, Dhanonjoy C ^a,b   Astiz, Mark E ^a   Lin, Robert Y ^a   Rackow, Eric C ^a   Eales, Lesley J ^b  

^a ST VINCENT S HOSPITAL   (United States)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

LPS; Monocytes; MPL; Nitric oxide; Nitric oxide synthase

Indexed keywords

LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHORYL LIPID A;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ARGINASE; ENZYME INHIBITORS; HUMANS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; LIPID A; LIPOPOLYSACCHARIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; STIMULATION, CHEMICAL; UP-REGULATION;

EID: 0030834434     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00045-3     Document Type: Article

References (41)

1. Assreuy J., Cunha F.Q., Liew F.Y., Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol. 108:1993;833-837.
2. Astiz M.E., Rackow E.C., Still J.G., Howell S.T., Cato A., Von Eschen K.B., Ulrich J.T., Rudbach J.A., McMahon G., Vargas R., Stern W. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: A prospective, double-blind, randomized, controlled trial. Crit. Care Med. 23:1995;9-17.
3. Billiar T.R. Nitric oxide: Novel biology with clinical relevance. Ann. Surg. 221:1995;339-349.
4. Boyum, A., Berg, T., Blomhoff, R., 1983. Fractionation of mammalian cells. In: Rickwood, D. (Ed.), Iodinatechnodensity Gradient Media: A Practical Approach. IRL Press, Oxford, pp. 147-171.
5. De Maria R., Cifone M.G., Trotta R., Rippo M.R., Festuccia C., Santoni A., Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 180:1994;1999-2004.
6. Denis, M., 1994a. Tumor necrosis factor and granulocyte macrophage colony-stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukocyte Biol. 49, 380-387.
7. Denis, M., 1994b. Human monocytes/macrophages: NO or no NO? J. Leukocyte Biol. 55, 682-684.
8. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141:1988;2407-2412.
9. Dugas B., Mossalayi M.D., Damais C., Kolb J.-P. Nitric oxide production by human monocytes: Evidence for a role of CD23. Immunol. Today. 16:1995;574-580.
10. Forstermann U., Pollock J.S., Tracey W.R., Nakane M. Isoforms of nitric oxide synthase: Purification and regulation. Methods Enzymol. 233:1994;258-264.
11. Griffith O.W., Stuehr D.J. Nitric oxide synthases: Properties and catalytic mechanism. Annu. Rev. Physiol. 57:1995;707-736.
12. Gustafson G.L., Rhodes M.J. A rationale for the prophylactic use of monophosphoryl lipid A in sepsis and septic shock. Biochem. Biophys. Res. Commun. 182:1992;269-275.
13. Hevel J.M., Marletta M.A. Nitric oxide synthase assays. Methods Enzymol. 233:1994;250-258.
14. Hunt N.C.A., Goldin R.D. Nitric oxide production by monocytes in alcoholic liver disease. J. Hepatol. 14:1992;146-150.
15. James S.L., Cook K.W., Lazdins J.K. Activation of human monocyte-derived macrophages to kill schistosoma of Schistosoma mansoni in vitro. J. Immunol. 145:1990;2686-2690.
16. Kang Y.-H., Lee C.-H., Monroy R.L., Dwivedi R.S., Odeyale C., Newball H.H. Uptake, distribution and fate of bacterial lipopolysaccharides in monocytes and macrophages: An ultrastructural and functional correlation. Electron. Microsc. Rev. 5:1992;381-419.
17. Kolb J.P., Paul-Eugene M., Damais C., Yamaoka K., Drapier J.C., Dugas B. Interleukin-4 stimulates cGMP production by INF-γ-activated human monocytes. Involvement of the nitric oxide synthase pathway. J. Biol. Chem. 269:1994;9811-9816.
18. Konur A., Krause S.W., Rehli M., Kreutz M., Andreesen R. Human monocytes induce a carcinoma cell line to secrete high amounts of nitric oxide. J. Immunol. 157:1996;2109-2115.
19. Leibovich S.J., Polverini P.J., Fong T.W., Harlow L.A., Koch A.E. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA. 91:1994;4190-4194.
20. Lin R.Y., Astiz M.E., Saxon J.C., Rackow E.C. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14 and IL-2R expression. Chest. 104:1993;857-863.
21. Loken M.R., Brosnan J.M., Bach B.A., Ault K.A. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry. 11:1990;453-459.
22. Martin J.H.J., Edwards S.W. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor killing. J. Immunol. 150:1993;3478-3486.
23. Mautino G., Paul-Eugene N., Chanez P., Vignola A.M., Kolb J.P., Bousquet J., Dugas B. Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J. Leukocyte Biol. 56:1994;15-20.
24. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB. 6:1992;3051-3064.
25. Palacios M., Knowles R.G., Moncada S. Enhancers of nonspecific immunity induce nitric oxide synthase: Induction does not correlate with toxicity or adjuvancy. Eur. J. Immunol. 22:1992;2303-2307.
26. Pietraforte D., Tritarelli E., Testa U., Minetti M. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leukocyte Biol. 55:1994;175-182.
27. Reiling N., Ulmer A.J., Duchrow M., Ernst M., Flad H.-D., Hauschild S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 24:1994;1941-1944.
28. Rittig M.G., Fabian D., Jantschke H., Krause A., Stuhlmuller B., Burmester G.R. Nitric oxide production by human peripheral blood monocytes in vitro as determined by an improved colorimetric assay. Immunobiol. 194:1995;85-86. (Abstract).
29. Rogers N.E., Ignarro L.J. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem. Biophys. Res. Commun. 189:1992;242-249.
30. Rudbach, J.A., Myers, K.R., Rechtman, D.J., Ulrich, J.T., 1994. Prophylactic use of monophosphoryl lipid A in patients at risk for sepsis. In: Levin, J., Van Deventer, S.J.H., Sturk, A., Van Der Poll, T. (Eds.), Bacterial Endotoxins: Basic Science to Anti-Sepsis Strategies. Wiley-Liss, New York, pp. 107-124.
31. Saha D.C., Lin R.Y., Astiz M.E., Rackow E.C., Eales L.-J. Differential regulation of cell surface receptors expression by lipopolysaccharide and monophosphoryl lipid A in human monocytes in vitro. J. Invest. Med. 43:1995;358A. (Abstract).
32. Schneemann M., Schoedon G., Hofer S., Blau N., Guerrero L., Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1993;1358-1363.
33. Siedlar M., Marcinkiewicz J., Zembala M. MHC class I and class II determinants and some adhesion molecules are engaged in the regulation of nitric oxide production in vitro by human monocytes stimulated with colon carcinoma cells. Clin. Immunol. Immunopathol. 77:1995;380-384.
34. Takayama K., Qureshi N., Ribi E., Cantrell J.L. Separation and characterization of toxic and nontoxic forms of lipid A. Rev. Infect. Dis. 6:1984;439-443.
35. Ulrich J.T., Masihi K.N., Lange W. Mechanisms of nonspecific resistance to microbial infections induced by trehalose dimycolate (TDM) and monophosphoryl lipid A (MPL). Adv. Biosci. 68:1988;167-178.
36. Ulrich, J.T., Myers, K.R., 1995. Monophosphoryl lipid A as an adjuvant: Past experience and new directions. In: Powell, M.F., Newman, M.J. (Eds.), Vaccine Design: The Subunit and Adjuvant Approach. Plenum Press, New York, pp. 495-524.
37. Vodovotz Y., Kwon N.S., Pospischil M., Manning J., Paik J., Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-γ and bacterial lipopolysaccharide. J. Immunol. 152:1994;4110-4118.
38. Weinberg J.B., Misukonis M.A., Shami P.J., Mason S.N., Sauls D.L., Dittman W.A., Wood E.R., Smith G.K., McDonald B., Bachus K.E., Haney A.F., Granger D.L. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood. 86:1995;1184-1195.
39. Zembala M., Siedlar M., Marcinkiewicz J., Pryima J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur. J. Immunol. 24:1994;435-439.
40. Zhou F., Huang L. Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes. Vaccine. 11:1993;1139-1144.
41. Zinetti M., Fantuzzi G., Delgado R., Di Santo E., Ghezzi P., Fratelli M. Endogenous nitric oxide production by human monocytic cells regulates LPS-induced TNF production. Eur. Cytokine Net. 6:1995;45-48.